GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40080)

  • GC80941 structure
    GC80941RJS308 TFA
    Purity: >98.00%

    RJS308 TFA is a selective Cyclophilin A ( CypA) PROTAC degrader.

  • GC80942 structure
    GC80942IRF4 ligand-1
    CAS: 3113827-15-6
    Purity: >99.00%

    IRF4 ligand-1 is an IRF4 ligand that can be used for the synthesis of PROTACs, such as dIRF4-2 [1] .

  • GC80943 structure
    GC80943KT-474 hydrochloride
    CAS: 2751703-31-6
    Purity: >98.00%

    KT-474 (KYM-001; PROTAC IRAK4 degrader-7) hydrochloride is an orally active PROTAC IRAK4 degrader with anti-tumor effects.

  • GC80944 structure
    GC80944PROTAC BCL6 Degrader-3
    CAS: 3005272-58-9
    Purity: >99.50%

    PROTAC BCL6 Degrader-3 (compound 92) is a BCL6 PROTAC degrader.

  • GC80945 structure
    GC80945APH02174 hemiformic
    Purity: >98.00%

    APH02174 hemiformic is a highly selective and orally active IRAK4 PROTAC degrader with the DC 50 of 4.01 nM in THP-1 cells.

  • GC80946 structure
    GC80946PROTAC JAK1/2 degrader-1
    Purity: >99.00%

    PROTAC JAK1/2 degrader-1 is an orally active JAK1 / JAK2 PROTAC degrader, with DC 50 values of 1.4 μM and 0.92 μM against JAK1 and JAK2, respectively.

  • GC80947 structure
    GC80947JAK1/2 ligand 1
    CAS: 1026028-96-5
    Purity: >99.50%

    JAK1/2 ligand 1 is a ligand for the PROTAC target protein of JAK1/2, which can be used to synthesize PROTAC JAK1/2 degrader-1.

  • GC80948 structure
    GC80948CRBN ligand-882
    CAS: 1512414-62-8
    Purity: >98.00%

    CRBN ligand-882 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80949 structure
    GC80949PROTAC STAT6 degrader-3
    CAS: 3077385-98-6
    Purity: >98.00%

    PROTAC STAT6 degrader-3 is a potent STAT6 PROTAC degrader with a DC 50 of less than 1 nM.

  • GC80950 structure
    GC80950CRBN ligand-881
    CAS: 92137-90-1
    Purity: >99.00%

    CRBN ligand-881 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80951 structure
    GC80951Hydrouracil-3-PhOH
    CAS: 1310680-01-3
    Purity: >98.00%

    Hydrouracil-3-PhOH is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80952 structure
    GC80952CRBN ligand-885
    CAS: 2758531-21-2
    Purity: >98.00%

    CRBN ligand-885 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80953 structure
    GC80953CRBN ligand-225
    CAS: 83809-75-0
    Purity: >98.00%

    CRBN ligand-225 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80954 structure
    GC80954CRBN ligand-883
    CAS: 1502483-16-0
    Purity: >99.50%

    CRBN ligand-883 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80955 structure
    GC80955Hydrouracil-3-Ph-COOH
    CAS: 2377644-59-0
    Purity: >98.50%

    Hydrouracil-3-Ph-COOH is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80956 structure
    GC80956CRBN ligand-224
    CAS: 2599846-40-7
    Purity: >98.50%

    CRBN ligand-224 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80957 structure
    GC80957CRBN ligand-891
    CAS: 2618349-23-6
    Purity: >95.00%

    CRBN ligand-891 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80958 structure
    GC80958Hydrouracil-4-fluorobenzoate
    CAS: 2377643-38-2
    Purity: >98.00%

    Hydrouracil-4-fluorobenzoate is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80959 structure
    GC80959E3 ligase Ligand 79
    CAS: 2152672-96-1
    Purity: >98.00%

    E3 ligase Ligand 79 is a CRBN E3 ligase ligand that can be used for synthesis of PROTACs [1] .

  • GC80960 structure
    GC80960Desamino lenalidomide-6-OH
    CAS: 1416990-09-4
    Purity: >99.00%

    Desamino lenalidomide-6-OH is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80961 structure
    GC80961Desamino lenalidomide-7-OH
    CAS: 1416990-10-7
    Purity: >99.00%

    Desamino lenalidomide-7-OH is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80962 structure
    GC80962Desamino lenalidomide-5-F
    CAS: 2468780-76-7
    Purity: >97.50%

    Desamino lenalidomide-5-F is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80963 structure
    GC80963Desamino lenalidomide-7-F
    CAS: 2287267-33-6
    Purity: >98.00%

    Desamino lenalidomide-7-F is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80964 structure
    GC80964CRBN ligand-888
    CAS: 53727-25-6
    Purity: >99.00%

    CRBN ligand-888 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.